Compound class:
Synthetic organic
Comment: I-C11 is an inhibitor of the PTPN22 tyrosine phosphatase [1-2]. It binds both the active (orthosteric) site and an allosteric, PTPN22 unique site (S35TKYKADK42) that confers selectivity. The chemical structure for I-C11 is claimed in patent WO2009049098A2 [3].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Stanford SM, Krishnamurthy D, Falk MD, Messina R, Debnath B, Li S, Liu T, Kazemi R, Dahl R, He Y et al.. (2011)
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J Med Chem, 54 (6): 1640-54. [PMID:21341673] |
2. Yu X, Sun JP, He Y, Guo X, Liu S, Zhou B, Hudmon A, Zhang ZY. (2007)
Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc Natl Acad Sci USA, 104 (50): 19767-72. [PMID:18056643] |
3. Zhang Z-Y, He Y. (2009)
Materials and methods for regulating the activity of phosphatases. Patent number: WO2009049098A2. Assignee: INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION. Priority date: 06/05/2019. Publication date: 16/04/2009. |